{"_buckets": {"deposit": "66da791c-d70e-4cfa-9130-dde1c5943e98"}, "_deposit": {"created_by": 3, "id": "1289", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "1289"}, "status": "published"}, "_oai": {"id": "oai:dmu.repo.nii.ac.jp:00001289", "sets": ["77"]}, "author_link": ["6396", "6395", "6392", "6393", "6397", "6398", "6394"], "item_2_biblio_info_12": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2016-03-25", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "13", "bibliographicPageStart": "5", "bibliographicVolumeNumber": "43", "bibliographic_titles": [{"bibliographic_title": "Dokkyo journal of medical sciences"}]}]}, "item_2_description_11": {"attribute_name": "抄録(英)", "attribute_value_mlt": [{"subitem_description": "Aims:The goal of this study was to investigate the effect of switching from either the low dose sulfonylurea glimepiride(1?mg once daily)or the glinide mitiglinide(10?mg three times daily)to repaglinide(0.5?mg three times daily)on both glycemic control and oxidative stress in patients with type 2 diabetes.Patients and Methods:Finally 17 patients(patients treated with either glimepiride:n=11 or mitiglinide:n=6)completed the study. The type and dose of all drugs, including the anti-diabetic treatments, were not changed for at least 1?month prior to the study.Results:Both groups showed a significant decrease in HbA1c levels. FPG showed a tendency(not significant)toward a decrease in the mitiglinide-treated group, while no change was found in the glimepiride-treated group. A significant decrease in 8-iso-PGF2α levels was found only in the glimepiride-treated group. There was a significant correlation between the difference in 8-iso-PGF2α levels and that in either FPG or HbA1c before and after the switch only in the mitiglinide-treated group.Conclusions:Repaglinide may have an anti-oxidative effect probably due to the strong postprandial glucose lowering observed in patients with type 2 diabetes.", "subitem_description_type": "Other"}]}, "item_2_description_15": {"attribute_name": "表示順", "attribute_value_mlt": [{"subitem_description": "3", "subitem_description_type": "Other"}]}, "item_2_description_16": {"attribute_name": "アクセション番号", "attribute_value_mlt": [{"subitem_description": "KJ00010141600", "subitem_description_type": "Other"}]}, "item_2_description_9": {"attribute_name": "記事種別(英)", "attribute_value_mlt": [{"subitem_description": "Original", "subitem_description_type": "Other"}]}, "item_2_source_id_1": {"attribute_name": "雑誌書誌ID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00629581", "subitem_source_identifier_type": "NCID"}]}, "item_2_source_id_19": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "03855023", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_7": {"attribute_name": "著者所属(英)", "attribute_value_mlt": [{"subitem_text_language": "en", "subitem_text_value": "Department Of Internal Medicine, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Department Of Internal Medicine, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Department Of Internal Medicine, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Department Of Internal Medicine, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Department Of Internal Medicine, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Department Of Internal Medicine, Dokkyo Medical University Koshigaya Hospital"}, {"subitem_text_language": "en", "subitem_text_value": "Department Of Internal Medicine, Dokkyo Medical University Koshigaya Hospital"}]}, "item_2_title_3": {"attribute_name": "論文名よみ", "attribute_value_mlt": [{"subitem_title": "The Effect of Switching from Either Mitiglinide or Glimepiride to Repaglinide on Both Glycemic Control and Oxidative Stress in Patients with Type 2 Diabetes"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Inukai, Toshihiko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6392", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takebayashi, Kohzo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6393", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Terasawa, Tomoko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6394", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Naruse, Rika", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6395", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hara, Kenji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6396", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suetsugu, Mariko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6397", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tuchiya, Takafumi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "6398", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-05-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00010141600.pdf", "filesize": [{"value": "370.9 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 370900.0, "url": {"label": "KJ00010141600.pdf", "url": "https://dmu.repo.nii.ac.jp/record/1289/files/KJ00010141600.pdf"}, "version_id": "56de5f14-76fe-4f3e-bb54-103f619a75f2"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Repaglinide", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Oxidative Stress", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Type 2 Diabetes", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "The Effect of Switching from Either Mitiglinide or Glimepiride to Repaglinide on Both Glycemic Control and Oxidative Stress in Patients with Type 2 Diabetes", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The Effect of Switching from Either Mitiglinide or Glimepiride to Repaglinide on Both Glycemic Control and Oxidative Stress in Patients with Type 2 Diabetes", "subitem_title_language": "en"}]}, "item_type_id": "2", "owner": "3", "path": ["77"], "permalink_uri": "https://dmu.repo.nii.ac.jp/records/1289", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-05-24"}, "publish_date": "2017-05-24", "publish_status": "0", "recid": "1289", "relation": {}, "relation_version_is_last": true, "title": ["The Effect of Switching from Either Mitiglinide or Glimepiride to Repaglinide on Both Glycemic Control and Oxidative Stress in Patients with Type 2 Diabetes"], "weko_shared_id": 3}